| News

Basel researchers developing universal cancer therapy

26.01.2021

Researchers from Basel are working on the development of a therapy in which pre-prepared immune cells can be used to treat any form of cancer immediately after diagnosis. A startup now intends to use 30 million US dollars in seed funding to finance the transition towards clinical development.

Researcher and entrepreneur Lucia Mori (img: University of Basel, Oliver Hochstrasser)

Dr. Lucia Mori from the Department of Biomedicine at the University of Basel is working on the development of a revolutionary cancer therapy. According to a press release issued by the university, this would represent substantial progress even in comparison with personalized immune therapies. While these facilitate high-precision treatment, they also take time. “Wouldn’t it be great if we could just reach into the freezer following a cancer diagnosis, and have a ready-made pack of immune cells ready to go? Regardless of the type of cancer?”, Mori states, highlighting the key advantage of her solution.

Together with her colleagues, Mori, who was born in Italy, identified cells in the human immune system that would be able to attack various types of cancer cells as part of her research in Basel – “the best place in the world for immunological research”, she claims. These MR1T cells are able to detect tumors and attack MR1, which is a protein carried by nearly all cancer cells. In the lab, MR1T cells can be customized so that that they can be used to combat a whole host of cancer indications.

“Our aim is to manipulate T cells from healthy donors in such a way that they can target the combinations of MR1 and other characteristic molecules on the surface of cancer cells”, Mori explains in the press release. As these characteristics are often shared by the same cancer types, the relevant therapies could be prepared in advance. For example, this kind of treatment could be used to fight breast, bowel and lung cancers.

The focus is now on transitioning to clinical development. For this, Mori co-founded the start-up Matterhorn Biosciences, which has already raised 30 million US Dollars in seed financing from Versant Ventures.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

New innovation campus to be named Switzerland Innovation Park Basel Area Main Campus
Basel Area Business & Innovation, Innovation, Invest, Switzerland Innovation Park

New innovation campus to be named Switzerland Innovation Park Basel Area Main Campus

A new innovation campus is currently under construction in Allschwil. This will be known as Switzerland Innovation Park Basel Area...

Read More
Synendos Therapeutics expands financing to 24 million Swiss francs
Basel Area Business & Innovation, Innovation, Invest, Switzerland Innovation Park

Synendos Therapeutics expands financing to 24 million Swiss francs

Ysios Capital joins the existing consortium of European investors to expand the Series A financing for Synendos Therapeutics. The Allschwil-based...

Read More
Innosuisse funding new RocketVax coronavirus vaccine
Basel Area Business & Innovation, Innovation, Invest

Innosuisse funding new RocketVax coronavirus vaccine

Leading Swiss experts in immunology and virology have joined forces in the Basel-based startup RocketVax with the aim of developing...

Read More
MTIP using new fund to invest in innovative companies
Basel Area Business & Innovation, Innovation, Invest

MTIP using new fund to invest in innovative companies

The Basel-based firm MTIP AG specializes in investments in HealthTech companies. A total of 130 million euros has already been...

Read More
Basel Area records successful 2020
Basel Area Business & Innovation, Innovation, Invest

Basel Area records successful 2020

Basel Area Business & Innovation was able to newly settle a total of 27 companies in the Basel Area in...

Read More
BetterDoc opts for Basel
Basel Area Business & Innovation, Innovation, Invest

BetterDoc opts for Basel

The online medical service BetterDoc has selected Basel as its Swiss location. Together with the health insurance firm Assura, it...

Read More
1 2 3 11

Do you have a question? We'd like to hear from you.